Bottom line
What does XPH hold?
XPH held 67 positions as of Jun 30, 2026. Its largest holding is State Street Global Advisors at 8.58% of the fund, and the top 10 positions add up to 28.9%. By asset type it is 100% stocks, 9% cash & short-term funds.
Updated Aug 28, 2026
XPH top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | State Street Global Advisors State Street Navigator Securities Lending Portfolio II |
Cash & short-term funds | 8.58% | $36.8M |
| 2 | Definium Therapeutics Inc | Stocks | 3.09% | $13.2M |
| 3 | MBX Biosciences Inc | Stocks | 2.72% | $11.6M |
| 4 | Alumis Inc | Stocks | 2.14% | $9.2M |
| 5 | AtaiBeckley Inc | Stocks | 2.13% | $9.1M |
| 6 | Trevi Therapeutics Inc | Stocks | 2.12% | $9.1M |
| 7 | Enliven Therapeutics Inc | Stocks | 2.09% | $9.0M |
| 8 | Amylyx Pharmaceuticals Inc | Stocks | 2.04% | $8.7M |
| 9 | VeraDermics Inc | Stocks | 2.02% | $8.6M |
| 10 | Ligand Pharmaceuticals Inc | Stocks | 1.94% | $8.3M |
| 11 | Nuvation Bio Inc | Stocks | 1.89% | $8.1M |
| 12 | Edgewise Therapeutics Inc | Stocks | 1.88% | $8.1M |
| 13 | Nektar Therapeutics | Stocks | 1.88% | $8.0M |
| 14 | Liquidia Corp | Stocks | 1.86% | $8.0M |
| 15 | Maze Therapeutics Inc | Stocks | 1.85% | $7.9M |
| 16 | Harrow Inc | Stocks | 1.81% | $7.7M |
| 17 | EyePoint Inc | Stocks | 1.77% | $7.6M |
| 18 | Amneal Pharmaceuticals Inc | Stocks | 1.72% | $7.4M |
| 19 | Ocular Therapeutix Inc | Stocks | 1.71% | $7.3M |
| 20 | Corcept Therapeutics Inc | Stocks | 1.70% | $7.3M |
| 21 | Crinetics Pharmaceuticals Inc | Stocks | 1.66% | $7.1M |
| 22 | Pacira BioSciences Inc | Stocks | 1.65% | $7.1M |
| 23 | Merck & Co Inc | Stocks | 1.65% | $7.1M |
| 24 | Indivior Pharmaceuticals Inc | Stocks | 1.64% | $7.0M |
| 25 | Elanco Animal Health Inc | Stocks | 1.64% | $7.0M |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 28, 2026